These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18302508)

  • 1. Mechanisms of the anabolic effects of teriparatide on bone: insight from the treatment of a patient with pycnodysostosis.
    Chavassieux P; Asser Karsdal M; Segovia-Silvestre T; Neutzsky-Wulff AV; Chapurlat R; Boivin G; Delmas PD
    J Bone Miner Res; 2008 Jul; 23(7):1076-83. PubMed ID: 18302508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.
    Fratzl-Zelman N; Valenta A; Roschger P; Nader A; Gelb BD; Fratzl P; Klaushofer K
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1538-47. PubMed ID: 15070910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Recker RR; Marin F; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Farrerons J; Sanz B; Oertel H; Stepan J
    J Bone Miner Res; 2009 Aug; 24(8):1358-68. PubMed ID: 19338452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.
    Chen P; Miller PD; Recker R; Resch H; Rana A; Pavo I; Sipos AA
    J Bone Miner Res; 2007 Aug; 22(8):1173-80. PubMed ID: 17451369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.
    Riggs BL; Parfitt AM
    J Bone Miner Res; 2005 Feb; 20(2):177-84. PubMed ID: 15647810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
    Chen P; Jerome CP; Burr DB; Turner CH; Ma YL; Rana A; Sato M
    J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide.
    Lindsay R; Cosman F; Zhou H; Bostrom MP; Shen VW; Cruz JD; Nieves JW; Dempster DW
    J Bone Miner Res; 2006 Mar; 21(3):366-73. PubMed ID: 16491283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erosive arthritis in a patient with pycnodysostosis: an experiment of nature.
    Ainola M; Valleala H; Nykänen P; Risteli J; Hanemaaijer R; Konttinen YT
    Arthritis Rheum; 2008 Nov; 58(11):3394-401. PubMed ID: 18975331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
    Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK
    Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis.
    Ma YL; Zeng Q; Donley DW; Ste-Marie LG; Gallagher JC; Dalsky GP; Marcus R; Eriksen EF
    J Bone Miner Res; 2006 Jun; 21(6):855-64. PubMed ID: 16753016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein.
    Ho N; Punturieri A; Wilkin D; Szabo J; Johnson M; Whaley J; Davis J; Clark A; Weiss S; Francomano C
    J Bone Miner Res; 1999 Oct; 14(10):1649-53. PubMed ID: 10491211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
    Arlot M; Meunier PJ; Boivin G; Haddock L; Tamayo J; Correa-Rotter R; Jasqui S; Donley DW; Dalsky GP; Martin JS; Eriksen EF
    J Bone Miner Res; 2005 Jul; 20(7):1244-53. PubMed ID: 15940379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis.
    Zanchetta JR; Bogado CE; Ferretti JL; Wang O; Wilson MG; Sato M; Gaich GA; Dalsky GP; Myers SL
    J Bone Miner Res; 2003 Mar; 18(3):539-43. PubMed ID: 12619939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High bone mineral density in pycnodysostotic patients with a novel mutation in the propeptide of cathepsin K.
    Schilling AF; Mülhausen C; Lehmann W; Santer R; Schinke T; Rueger JM; Amling M
    Osteoporos Int; 2007 May; 18(5):659-69. PubMed ID: 17206399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K.
    Kiviranta R; Morko J; Uusitalo H; Aro HT; Vuorio E; Rantakokko J
    J Bone Miner Res; 2001 Aug; 16(8):1444-52. PubMed ID: 11499867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in micro-CT 3D bone parameters reflect effects of a potent cathepsin K inhibitor (SB-553484) on bone resorption and cortical bone formation in ovariectomized mice.
    Xiang A; Kanematsu M; Kumar S; Yamashita D; Kaise T; Kikkawa H; Asano S; Kinoshita M
    Bone; 2007 May; 40(5):1231-7. PubMed ID: 17347064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.
    Dobnig H; Stepan JJ; Burr DB; Li J; Michalská D; Sipos A; Petto H; Fahrleitner-Pammer A; Pavo I
    J Bone Miner Res; 2009 Dec; 24(12):1998-2006. PubMed ID: 19453263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.